Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05769114

Surgical Versus Non-Surgical Treatment of Thoracolumbar Burst Fracture

Treatment for acute traumatic thoracolumbar burst fractures differs significantly across the world in patients without neurological impairments and without damage to the posterior column of the spine. This randomized controlled, non-inferiority clinical trial's goal is to evaluate the effectiveness of surgery versus initial non-surgical treatment for patients with traumatic thoracolumbar spine burst fractures who don't have any neurological symptoms.

The study's precise objectives are to:

1. evaluate the clinical outcome (Oswestry Disability Index) 2. evaluate the radiography result (restoration and maintenance of spinal alignment) 3. determine the prevalence of complications

at least 24 months of follow-up of neurologically unaffected patients with acute traumatic burst fractures. Both groups will get the same therapy using standardized methods: The surgical group's entire patient population will get combined anterior-posterior (360°) spinal fusion therapy. Three-point hyperextension orthoses will be used to treat all patients in the non-surgical group for six weeks following the injury.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Inselspital, Bern, Switzerland

Loading trial locations.

About this study

The research is a single-center, nationwide, randomized controlled trial. Over a two-year period, 52 patients with a thoracolumbar burst fracture will enroll in the study. They will be assigned randomly (1:1) to either non-surgical treatment with a brace or surgery with anterior-posterior fixation. A prospective data collection will be asked of subjects who decline randomization (observational arm). The subjects will be evaluated clinically, radiologically, and based on patient-reported outcomes over the course of two years. Both patient files and questionnaires will be used to collect data.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 - 70 years at inclusion
  • Acute traumatic burst fracture of the thoracolumbar spine (10th thoracic to 3rd lumbar vertebral body)
  • Informed consent for study participation

Exclusion criteria

  • Injury of the posterior tension band/posterior column of the thoracolumbar spine
  • Any neurological deficit (American Spinal Injury Association Impairment Scale [AISA] Grade A-D)
  • Pathological vertebral body fractures (diagnosed by MRI and CT scan), which, in the opinion of the research/investigative team, would compromise (or interfere with) patients' ability to participate in the study
  • Concomitant spinal fractures at any other level of the spine outside the T10-L3 level, which, in the opinion of the research/investigative team, would compromise (or interfere with) patients' ability to participate in the study
  • Multiple trauma or Injury Severity Score (ISS) > 16 or additional injuries according to the investigator may, which, in the opinion of the research/investigative team, would compromise (or interfere with) patients' ability to participate in the study (impairment of early ambulation)
  • Any known previous spinal surgery in the thoracolumbar spine, which, in the opinion of the research/investigative team, would compromise (or interfere with) patients' ability to participate in the study
  • Any severe, progressive, or uncontrolled medical or psychiatric condition, or other factors at randomization that in the judgment of the investigator prevents the patient from participating in the study
  • Known history of substance abuse (i.e., recreational drugs, alcohol) that would preclude reliable assessment in the opinion of the investigator
  • Pregnancy or women planning to conceive within the study period. All women included in this study must have a negative blood pregnancy test (human chorionic gonadotrophin (hCG) blood level at visit 1. If pregnancy occurs during the study period, the patients drop out of the study
  • Inability to follow the procedures of the study, e.g., due to inability to understand German, French or English, which, according to the investigator, may jeopardize the patient in case of participation in the study or prevents the patient from participating in the study

Treatment and study plan

surgical stabilization

Procedure

Anterior-posterior stabilization (360°) with pedicle screws and an expandable cage

Other names: 360°-Stabilization

Primary outcomes

  1. The clinical outcome as assessed by the Oswestry Disability Index (ODI) 104 weeks post-surgery or non-surgical treatment initiation

    Time frame: 2 years after fracture

    ODI is a patient-reported outcome measure for spinal disorders. It consists of 10 questions related to back specific disabilities such as pain, personal care, walking and sitting ability, lifting capacity and social life.

Secondary outcomes

  1. Radiological outcome: Mono- (A3-fractures)/Bisegmental (A4-fractures) kyphosis angle

    Time frame: Pre-Treatment to 2 years after the fracture

    Bi-/segmental kyphosis (Gardner/Cobb angle) assessed by long-standing x-rays of the entire spine

  2. Radiological outcome: Spinal fusion and fracture consolidation

    Time frame: 26 weeks after fracture

    Spinal fusion in the surgical group and fracture consolidation in the non-surgical group assessed by CT-scan

  3. Radiological outcome: Segment mobility

    Time frame: 52 weeks after fracture

    Segment mobility assessed by functional lateral views at 52 weeks and compared between treatment groups

  4. Radiological outcome: Degeneration of the intervertebral disc over time

    Time frame: Pre-Treatment, 52 weeks after the fracture

    Degeneration of the intervertebral disc (Pfirrmann grade)

  5. Radiological outcome: Progression of spinal canal stenosis

    Time frame: From the time of fracture, 26 weeks and 52 weeks

    Assessed on CT-scan and MRI

  6. Non-surgical treatment failure rate

    Time frame: From the time of fracture to 2 years after the fracture

    Proportion/frequency of patients in the non-surgery group that received surgery later, if there is a clinical indication (spinal instability measured by a kyphosis > 30 degrees on x-ray, intolerable pain, delayed onset of neurological symptoms) or if the patient is not satisfied after treatment

  7. Complication rate and severity and additional surgeries

    Time frame: 6, 12, 26, 52, and 104 weeks

    Rate and severity according to the Spine Adverse Events Severity System (SAVES) and surgical complications between treatment groups

  8. Changes in patient-related outcome measurements: AOSpine Patient Reported Outcome Spine Trauma (PROST)

    Time frame: From the time of fracture to 2 years after the fracture

    Changes between groups and from baseline to follow-up 104 weeks and compared between treatment groups

  9. Changes in patient-related outcome measurements: EQ5D-3L

    Time frame: Pre-Treatment to 2 years after the fracture

    Changes between groups and from baseline to follow-up 104 weeks and compared between treatment groups

  10. Changes in patient-related outcome measurements: Pain visual analogue scale (VAS)

    Time frame: Pre-Treatment to 2 years after the fracture

    Changes between groups and from baseline to follow-up 104 weeks and compared between treatment groups

  11. Indirect costs

    Time frame: 6, 12, 26, 52, and 104 weeks

    Assessed by indirect cost questionnaire and compared between treatment groups

  12. Treatment data: Length of hospitalization (days)

    Time frame: Pre-Treatment to discharge from hospital

    Inhospital data records, comparison between treatment groups

  13. Treatment data: blood loss during surgery (ml)

    Time frame: during surgery

    Inhospital data records

  14. Treatment data: duration of surgery (hh: mm)

    Time frame: during surgery

    Inhospital data records

  15. Time to return to work/sports

    Time frame: 6, 12, 26, 52, and 104 weeks

    Documented at each clinical follow-up as internal clinic standard of care, comparison between treatment groups

  16. Radiological outcome: Sagittal and coronal alignment

    Time frame: 6, 12, 26, 52, and 104 weeks

    Assessed by long-standing x-rays of the entire spine, comparison between treatment groups

  17. Opioid use

    Time frame: Pre-Treatment, 6, 12, 26, 52, and 104 weeks

    Use of oral intake of opioids, comparison between treatment groups and changes from baseline to 104 weeks

Other outcomes

  1. Radiological outcome: Fracture comminution

    Time frame: Pre-Treatment

    Fracture comminution of the vertebral body

  2. Radiological outcome: Classification of traumatic disc injury

    Time frame: Pre-treatment

    Sanders Classification

Study contacts

Contact information is provided by the study sponsor or research team.

Christoph E Albers, PD Dr.

CONTACT

[email protected]

+41 (0) 31 664 04 40

Sonja Häckel, Dr.

CONTACT

[email protected]

+41 (0) 31 664 04 40

Sponsors and collaborators

Lead sponsor

Insel Gruppe AG, University Hospital Bern

Other

Collaborators

  • Cantonal Hospital of St. Gallen

Registry information

Official study title

Outcome of Surgical Versus Primary Non-Surgical Treatment of Traumatic Thoracolumbar Spine Burst Fracture in Patients Without Neurological Symptoms: A Randomized Controlled Clinical Trial

Acronym: A34RCT

Important dates

Study start
2023
Primary completion
2027
Study completion
2030
First posted
Mar 15, 2023
Registry last updated
May 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.